Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
KIDNEY XENOTRANSPLANTATION - THE NEXT GREAT BREAKTHROUGH IN NEPHROLOGY? David K.C. Cooper MD, PhD, FRCS Thomas E. Starzl Transplantation Institute University of Pittsburgh COMPETING INTERESTS I am Chairman of the Scientific Advisory Board of Revivicor, Inc., Blacksburg, VA, but I have no financial interest in the company and do not receive any remuneration whatsoever. REVIVICOR Small biotechnology company (25 staff) that concentrates its effort on the genetic engineering of pigs for medical purposes: 1. Xenotransplantation 2. Human immunoglobulin (also for biodefense) ACKNOWLEDGEMENTS Many colleagues at STI, Allegheny General Hospital, and Revivicor HISTORY OF XENOTRANSPLANTATION XENOTRANSPLANTATION: THE PIG AS THE ORGAN-SOURCE XENOTRANSPLANTATION Advantages 1: 1. Unlimited supply of donor organs. 2. Organs available electively. 3. Avoids effects of brain death. 4. Infection-free donors. XENOTRANSPLANTATION Advantages 2: 1. Borderline candidates 2. “Cultural” barriers to deceased donation (e.g. Japan) 3. Diabetes mellitus/cell transplants CLINICAL PIG-TO-HUMAN XENOTRANSPLANTATION Organs (kidney, heart, liver, lung) Islets Corneas Neuronal cells Hepatocytes Skin Red blood cells XENOTRANSPLANTATION: BARRIERS BARRIERS TO XENOTRANSPLANTATION IMMUNOLOGIC Physiologic Safety (risk of infection) Ethical Regulatory / Legal BARRIERS TO XENOTRANSPLANTATION “Immunologic” includes: 1. Innate immune response (e.g., antibody, complement, macrophages) 2. Adaptive immune response (e.g., T and B cells) 3. Coagulation dysfunction (e.g., thrombin, platelets) 4. Inflammation PIG ORGAN XENOTRANSPLANTATION IN NONHUMAN PRIMATES PIG-TO-BABOON KIDNEY TX (DAY 0) PIG-TO-BABOON KIDNEY TX (HAR) PORCINE HUMAN αGal ABH NeuGc NeuAc ß4GalNT2 XENOTRANSPLANTATION: EXPERIMENTAL PROGRESS Solution 1 Gene-knockout of known antigenic targets for human anti-pig antibodies, e.g., αGal, NeuGc, ß4GalNT2 D /C O an O 6 um cK 46 IgM H eu G D 8 46 /N /C 0 O * TK * T 20 Relative MFI 30 W um an O 10 H cK eu G 46 40 G 46 /N D /C * TK D /C O O 50 G TK G TK G T W Relative MFI Human antibody binding to the AECs IgG * * 4 * 2 0 *p<0.05 (n=6) Solution 2 Pigs transgenic for a human protein, e.g., complementregulatory, coagulationregulatory, anti-inflammatory, immunosuppressive agent Surface expression on genetically-engineered (GE) pig and human aortic endothelial cells (AECs) Isotype GE pig AECs CD46 CD55 (DAF) CD141 (TBM) CD46 CD55 (DAF) CD141 (TBM) Human AECs GENETICALLY-ENGINEERED PIGS CURRENTLY AVAILABLE Revivicor has produced pigs with 20 different genetic manipulations Some pigs have 7 modifications Worldwide, 40 different manipulations ELICITED ANTI-PIG ANTIBODIES Unless prevented by immunosuppressive therapy, after exposure to a pig organ or cells, anti-pig antibodies can increase >10-fold PROGRESS IN PIG-TO-NHP KIDNEY TX Progress in immunosuppressive therapy: Conventional (e.g., tacrolimus, steroids) Costimulation blockade (Genetically-engineered pigs) PROGRESS IN PIG-TO-NHP KIDNEY TX The Emory group had one monkey surviving >10 months with a lifesupporting pig kidney graft (The NIH group had two baboons surviving >1 year after a heterotopic heart graft) PIG-TO-NHP RENAL XENOTX GTKO/hDAF Rhesus macaque: T cell depletion, anti-CD154, MMF/steroids BARRIERS TO XENOTRANSPLANTATION Immunologic PHYSIOLOGIC Safety (risk of infection) Ethical Regulatory / Legal B9313 - INCREASE IN SIZE OF KIDNEY BARRIERS TO XENOTRANSPLANTATION Immunologic Physiologic SAFETY (RISK OF INFECTION) Ethical Regulatory / Legal SAFETY OF XENOTRANSPLANTATION Concern regarding potential transfer of infectious microorganisms to (1) recipient, (2) public SAFETY OF XENOTRANSPLANTATION ‘Remaining’ potential risk: Porcine endogenous retroviruses (PERVs) BARRIERS TO XENOTRANSPLANTATION Immunologic Physiologic Safety (risk of infection) ETHICAL REGULATORY / LEGAL GENETICALLY-ENGINEERED PIGS 1. No unacceptable implications for the health and welfare of the pig 2. No serious ethical objections to the genetic procedure - brain (pig or human) - reproduction of one species by the other The Netherlands “There are many ways of losing money. Women are the most fun. Gambling is the fastest. Research is the most certain.” Lord Hives Chairman of Rolls Royce GENETICALLY-ENGINEERED PIGS Recent new technologies, e.g., Zinc finger nucleases TALENS CRISPR/Cas9 will facilitate the production of pigs with multiple genetic modifications History tells us that procedures that were inconceivable yesterday, and are barely achievable today, often become routine tomorrow. Thomas E. Starzl, 1982 POTENTIAL ALTERNATIVES TO XENOTRANSPLANTATION 1. Human stem cells 2. Regenerative medicine 3. Cell-based mechanical devices FIRST CLINICAL TRIAL ? Patients highly-sensitized to alloantigens (high PRA) ? Patients with problems of vascular access for dialysis “It is often sufficient to know, in the large, that a thing may be possible” Littre, 1710 Royal Academy of Science Paris One day “making a pig of yourself” could have a whole new meaning THANK YOU